One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Genetic and epigenetic alterations in DNA repair genes and treatment outcome of chemoradiotherapy in cervical cancer
Atar Singh Kushwah a b c, Shireen Masood b, Rajnikant Mishra c, Monisha Banerjee b 1
doi : 10.1016/j.critrevonc.2023.104240
Volume 194, February 2024, 104240
The cell line models to study tyrosine kinase inhibitors in non-small cell lung cancer with mutations in the epidermal growth factor receptor: A scoping review
Alessia Belloni a, Armanda Pugnaloni a, Maria Rita Rippo a, Silvia Di Valerio a, Chiara Giordani b, Antonio Domenico Procopio a b, Giuseppe Bronte a b
doi : 10.1016/j.critrevonc.2023.104246
Volume 194, February 2024, 104246
Biomarkers of fatigue in oncology: A systematic review
Deveny Vanrusselt a b, Charlotte Sleurs a b c, Mahnoor Arif b, Jurgen Lemiere a b, Sabine Verschueren d, Anne Uyttebroeck a b
doi : 10.1016/j.critrevonc.2023.104245
Volume 194, February 2024, 104245
Progress in the treatment of malignant ascites
Yiqiu Wang a b c d, Yunting Sun e, Xinyue Li a b c d, Xiaoli Yu a b c d, Keying Zhang a b c d, Jinglei Liu a b c d, Qingchang Tian a b c d, Honghua Zhang a b c d, Xiao Du a b c d, Shuling Wang a b c d
doi : 10.1016/j.critrevonc.2023.104237
Volume 194, February 2024, 104237
Which is the best treatment for melanoma brain metastases? A Bayesian network meta-analysis and systematic review
Cong Li a 1, Kunhang Li a 1, Shiyu Zhong a, Mingzheng Tang b, Xin Shi c d e, Yijun Bao a
doi : 10.1016/j.critrevonc.2023.104227
Volume 194, February 2024, 104227
Geriatric predictors of response and adverse events in older patients with cancer treated with immune checkpoint inhibitors: A systematic review
Asli Özkan a, Frederiek van den Bos b, Simon P. Mooijaart b c, Marije Slingerland a, Ellen Kapiteijn a, Noel F.C.C. de Miranda d, Johanneke E.A. Portielje a, Nienke A. de Glas a
doi : 10.1016/j.critrevonc.2024.104259
Volume 194, February 2024, 104259
New immunotherapy approaches as the most effective treatment for uveal melanoma
Atefeh Eteghadi a, Maryam Ebrahimi b, Saeed Heidari keshel a b
doi : 10.1016/j.critrevonc.2024.104260
Volume 194, February 2024, 104260
Molecular biomarkers in prostate cancer tumorigenesis and clinical relevance
Nathalia Oliveira Alqualo 1, Esther Campos-Fernandez 2, Bianca Uliana Picolo 3, Emanuelle Lorrayne Ferreira 4, Laila Machado Henriques 5, Sabrina Lorenti 6, Danilo Caixeta Moreira 7, Maria Paula Silva Simião 8, Luciana Beatriz Tiago Oliveira 9, Vivian Alonso-Goulart 10 11
doi : 10.1016/j.critrevonc.2023.104232
Volume 194, February 2024, 104232
Liquid biopsy in colorectal cancer: Onward and upward
Sara Torresan a,b,1, Marco de Scordilli a,b,*,1, Martina Bortolot a,b, Paola Di Nardo a, Luisa Foltran a, Arianna Fumagalli a, Michela Guardascione a, Elena Ongaro a, Fabio Puglisi
doi : 10.1016/j.critrevonc.2023.104242
Volume 194, February 2024, 104242
Clinical evidence and adverse event management update of patients with RET- rearranged advanced non-small-cell lung cancer (NSCLC) treated with pralsetinib
Giuseppe Lo Russo a,1, Paolo Bironzo b,1, Chiara Bennati c, Laura Bonanno d, Annamaria Catino e, Giulio Metro f, Iacopo Petrini g, Marco Russano h, Antonio Passaro
doi : 10.1016/j.critrevonc.2023.104243
Volume 194, February 2024, 104243
Practical guidelines for molecular testing of cholangiocarcinoma in clinical practice: Italian experts’ position paper
Matteo Fassan a,b,1, Valentina Angerilli a,1, Nicola Normanno c, Giancarlo Pruneri d,e, Antonio Marchetti f, Federica Grillo g,h,*, Giuseppe Tonini i,j, Aldo Scarpa k,2, Lorenza Rimassa
doi : 10.1016/j.critrevonc.2023.104224
Volume 194, February 2024, 104224
The role of liquid biopsy in epithelial ovarian cancer: State of the art
Luigi Della Corte a,1, Gianluca Russo b,1, Francesco Pepe b, Pasquale Pisapia b, Michela Dell’Aquila b,*, Umberto Malapelle b, Giancarlo Troncone b, Giuseppe Bifulco b, Pierluigi Giampaolino
doi : 10.1016/j.critrevonc.2024.104263
Volume 194, February 2024, 104263
Brain metastases and next-generation anticancer therapies: a survival guide for clinicians
Angelo Dipasquale a, Chiara Barigazzi a,b, Agnese Losurdo a,b, Pasquale Persico a,b, Antonio Di Muzio a,b, Piera Navarria c, Federico Pessina b,d, Martin van den Bent e, Armando Santoro a,b,1, Matteo Simonelli
doi : 10.1016/j.critrevonc.2023.104239
Volume 194, February 2024, 104239
Cryotherapy for prevention of chemotherapy induced peripheral neuropathy in breast cancer
Mihir Tandon a, Melissa Yacur b, Christiana Brenin a, Patrick Dillon
doi : 10.1016/j.critrevonc.2023.104244
Volume 194, February 2024, 104244
Oncogenic fusions: Targeting NTRK
Garo Hagopian a, Misako Nagasaka
doi : 10.1016/j.critrevonc.2023.104234
Volume 194, February 2024, 104234
Blood-based liquid biopsy in advanced prostate cancer
Emilio Francesco Giunta a,*, Umberto Malapelle b, Antonio Russo c, Ugo De Giorgi
doi : 10.1016/j.critrevonc.2023.104241
Volume 194, February 2024, 104241
Efficacy and safety of neoadjuvant chemotherapy containing anti-angiogenic drugs, immunotherapy, or PARP inhibitors for ovarian cancer
Wanying Bao a,b, Zhengyu Li
doi : 10.1016/j.critrevonc.2023.104238
Volume 194, February 2024, 104238
Non-apoptotic cell death programs in cervical cancer with an emphasis on ferroptosis
Mohammad Samare-Najaf a,b,*, Ali Samareh c,**, Amir Savardashtaki d,e,***, Nastaran Khajehyar b, Amir Tajbakhsh f,g, Sina Vakili e,**, Delaram Moghadam a,h, Sanaz Rastegar i, Majid Mohsenizadeh b, Bahia Namavar Jahromi e, Asma Vafadar d, Reza Zarei
Deciphering the role of KRAS gene in oncogenesis: Focus on signaling pathways, genetic alterations in 3’UTR, KRAS specific miRNAs and therapeutic interventions
Yogita Chhichholiya a, Harsh Vikram Singh a, Rajesh Vashistha b, Sandeep Singh a, Anjana Munshi
doi : 10.1016/j.critrevonc.2023.104250
Volume 194, February 2024, 104250
Predictors of response to neoadjuvant therapy in urothelial cancer
Nishita Tripathi, Gliceida Galarza Fortuna, Georges Gebrael, Emre Dal, Vinay Mathew Thomas, Sumati Gupta, Umang Swami
doi : 10.1016/j.critrevonc.2023.104236
Volume 194, February 2024, 104236
Comprehensive review of solid tumor bone marrow metastasis
Lanxin Zhang a,1, Fengxi Chen a,1, Lingzhi Xu a,1, Ning Li b, Qiping Zhuo a, Yijin Guo a, Xueqing Wang a, Meijie Wen c, Zuowei Zhao a,d,*, Man Li
doi : 10.1016/j.critrevonc.2023.104248
Volume 194, February 2024, 104248
Microbiomes in pancreatic cancer can be an accomplice or a weapon
Xiaoyu Guo, Pan Wang *, Yuan Li, Yawei Chang, Xiaobing Wang
doi : 10.1016/j.critrevonc.2024.104262
Volume 194, February 2024, 104262
Immunotherapy and targeted therapy for cholangiocarcinoma: Artificial intelligence research in imaging
Jiong Liu a,b, Jian Shu
doi : 10.1016/j.critrevonc.2023.104235
Volume 194, February 2024, 104235
Efficacy and safety of mirvetuximab soravtansine in recurrent ovarian cancer with FRa positive expression: A systematic review and meta-analysis
Yicong Wang , Lifeng Liu , Xianyu Jin , Yongai Yu
doi : 10.1016/j.critrevonc.2023.104230
Volume 194, February 2024, 104230
